🔎 Trials Near Me

Hem › Alpha-1-antitrypsinbrist › Ohio

Kliniska studier för Alpha-1-antitrypsinbrist i Ohio

3 studier för Alpha-1-antitrypsinbrist söker deltagare vid platser i Ohio.

Städer i Ohio

Officiell studietext (engelska)

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

  • GC2501 Study Site 104, Cleveland
RekryterarFas 3
Ålder 18 till 80 · Alla kön · Uppdaterad 11 aug. 2026 · NCT07555483

Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

  • University Hospitals Cleveland Medical Center, Cleveland
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 13 maj 2026 · NCT05677971

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

  • University Hospitals Cleveland Medical Center, Cleveland
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 5 mars 2026 · NCT06165341

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.